vs

Side-by-side financial comparison of Organogenesis Holdings Inc. (ORGO) and ROYAL GOLD INC (RGLD). Click either name above to swap in a different company.

ROYAL GOLD INC is the larger business by last-quarter revenue ($375.3M vs $225.6M, roughly 1.7× Organogenesis Holdings Inc.). ROYAL GOLD INC runs the higher net margin — 24.9% vs 19.4%, a 5.6% gap on every dollar of revenue. On growth, ROYAL GOLD INC posted the faster year-over-year revenue change (85.3% vs 78.1%). Over the past eight quarters, ROYAL GOLD INC's revenue compounded faster (58.8% CAGR vs 43.2%).

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

Royal Gold Inc. is a leading precious metals streaming and royalty firm that acquires and manages a diversified portfolio of streaming interests, royalties, and equity interests tied to mining projects. Its assets cover gold, silver, and copper production across North America, South America, Africa, and Australia, operating with a low-risk model that avoids direct mining operations.

ORGO vs RGLD — Head-to-Head

Bigger by revenue
RGLD
RGLD
1.7× larger
RGLD
$375.3M
$225.6M
ORGO
Growing faster (revenue YoY)
RGLD
RGLD
+7.2% gap
RGLD
85.3%
78.1%
ORGO
Higher net margin
RGLD
RGLD
5.6% more per $
RGLD
24.9%
19.4%
ORGO
Faster 2-yr revenue CAGR
RGLD
RGLD
Annualised
RGLD
58.8%
43.2%
ORGO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ORGO
ORGO
RGLD
RGLD
Revenue
$225.6M
$375.3M
Net Profit
$43.7M
$93.6M
Gross Margin
64.6%
Operating Margin
28.1%
56.2%
Net Margin
19.4%
24.9%
Revenue YoY
78.1%
85.3%
Net Profit YoY
469.5%
-12.8%
EPS (diluted)
$0.31
$1.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ORGO
ORGO
RGLD
RGLD
Q4 25
$225.6M
$375.3M
Q3 25
$150.9M
$252.1M
Q2 25
$101.0M
$209.6M
Q1 25
$86.7M
$193.4M
Q4 24
$126.7M
$202.6M
Q3 24
$115.2M
$193.8M
Q2 24
$130.2M
$174.1M
Q1 24
$110.0M
$148.9M
Net Profit
ORGO
ORGO
RGLD
RGLD
Q4 25
$43.7M
$93.6M
Q3 25
$21.6M
$126.8M
Q2 25
$-9.4M
$132.3M
Q1 25
$-18.8M
$113.5M
Q4 24
$7.7M
$107.4M
Q3 24
$12.3M
$96.2M
Q2 24
$-17.0M
$81.2M
Q1 24
$-2.1M
$47.2M
Gross Margin
ORGO
ORGO
RGLD
RGLD
Q4 25
64.6%
Q3 25
73.6%
Q2 25
72.6%
Q1 25
72.6%
69.4%
Q4 24
75.5%
70.3%
Q3 24
76.7%
66.6%
Q2 24
77.6%
64.7%
Q1 24
73.9%
58.4%
Operating Margin
ORGO
ORGO
RGLD
RGLD
Q4 25
28.1%
56.2%
Q3 25
13.7%
64.4%
Q2 25
-12.5%
67.7%
Q1 25
-30.9%
63.6%
Q4 24
8.1%
65.9%
Q3 24
5.4%
61.3%
Q2 24
-10.7%
58.6%
Q1 24
-3.5%
50.7%
Net Margin
ORGO
ORGO
RGLD
RGLD
Q4 25
19.4%
24.9%
Q3 25
14.3%
50.3%
Q2 25
-9.3%
63.1%
Q1 25
-21.7%
58.7%
Q4 24
6.1%
53.0%
Q3 24
10.7%
49.7%
Q2 24
-13.1%
46.6%
Q1 24
-1.9%
31.7%
EPS (diluted)
ORGO
ORGO
RGLD
RGLD
Q4 25
$0.31
$1.04
Q3 25
$0.11
$1.92
Q2 25
$-0.10
$2.01
Q1 25
$-0.17
$1.72
Q4 24
$0.05
$1.63
Q3 24
$0.09
$1.46
Q2 24
$-0.13
$1.23
Q1 24
$-0.02
$0.72

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ORGO
ORGO
RGLD
RGLD
Cash + ST InvestmentsLiquidity on hand
$93.7M
$233.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$300.1M
$7.2B
Total Assets
$598.7M
$9.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ORGO
ORGO
RGLD
RGLD
Q4 25
$93.7M
$233.7M
Q3 25
$63.7M
$172.8M
Q2 25
$73.1M
$248.2M
Q1 25
$110.0M
$240.8M
Q4 24
$135.6M
$195.5M
Q3 24
$94.3M
$127.9M
Q2 24
$89.9M
$74.2M
Q1 24
$88.6M
$137.9M
Total Debt
ORGO
ORGO
RGLD
RGLD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
$0
Q2 24
$63.8M
$50.0M
Q1 24
$65.2M
Stockholders' Equity
ORGO
ORGO
RGLD
RGLD
Q4 25
$300.1M
$7.2B
Q3 25
$255.1M
$3.4B
Q2 25
$233.2M
$3.3B
Q1 25
$242.9M
$3.2B
Q4 24
$262.9M
$3.1B
Q3 24
$278.5M
$3.0B
Q2 24
$263.5M
$3.0B
Q1 24
$278.0M
$2.9B
Total Assets
ORGO
ORGO
RGLD
RGLD
Q4 25
$598.7M
$9.5B
Q3 25
$509.8M
$4.5B
Q2 25
$461.1M
$3.6B
Q1 25
$467.4M
$3.5B
Q4 24
$497.9M
$3.4B
Q3 24
$446.3M
$3.3B
Q2 24
$443.2M
$3.3B
Q1 24
$458.5M
$3.3B
Debt / Equity
ORGO
ORGO
RGLD
RGLD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
0.00×
Q2 24
0.24×
0.02×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ORGO
ORGO
RGLD
RGLD
Operating Cash FlowLast quarter
$39.4M
$241.7M
Free Cash FlowOCF − Capex
$34.8M
FCF MarginFCF / Revenue
15.4%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
0.90×
2.58×
TTM Free Cash FlowTrailing 4 quarters
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ORGO
ORGO
RGLD
RGLD
Q4 25
$39.4M
$241.7M
Q3 25
$3.1M
$174.0M
Q2 25
$-32.9M
$152.8M
Q1 25
$-19.9M
$136.4M
Q4 24
$10.9M
$141.1M
Q3 24
$8.7M
$136.7M
Q2 24
$4.7M
$113.5M
Q1 24
$-10.2M
$138.3M
Free Cash Flow
ORGO
ORGO
RGLD
RGLD
Q4 25
$34.8M
Q3 25
$844.0K
Q2 25
$-36.5M
Q1 25
$-23.6M
Q4 24
$7.6M
Q3 24
$6.1M
Q2 24
$2.9M
Q1 24
$-12.4M
FCF Margin
ORGO
ORGO
RGLD
RGLD
Q4 25
15.4%
Q3 25
0.6%
Q2 25
-36.1%
Q1 25
-27.2%
Q4 24
6.0%
Q3 24
5.3%
Q2 24
2.2%
Q1 24
-11.3%
Capex Intensity
ORGO
ORGO
RGLD
RGLD
Q4 25
2.1%
Q3 25
1.5%
Q2 25
3.6%
Q1 25
4.2%
Q4 24
2.7%
Q3 24
2.2%
Q2 24
1.4%
Q1 24
2.0%
Cash Conversion
ORGO
ORGO
RGLD
RGLD
Q4 25
0.90×
2.58×
Q3 25
0.14×
1.37×
Q2 25
1.15×
Q1 25
1.20×
Q4 24
1.43×
1.31×
Q3 24
0.71×
1.42×
Q2 24
1.40×
Q1 24
2.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ORGO
ORGO

Segment breakdown not available.

RGLD
RGLD

Gold$216.9M58%
Pueblo Viejo$47.3M13%
Andacollo$32.6M9%
Silver$32.1M9%
Other$27.2M7%
Copper$13.7M4%
Cortez Legacy Zone$5.4M1%

Related Comparisons